Guillain-Barré syndrome in Asia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 8, 2014, Pages 905-911

  Bae, Jong Seok ^a,b   Yuki, Nobuhiro ^c   Kuwabara, Satoshi ^d   Kim, Jong Kuk ^e   Vucic, Steve ^b,f   Lin, Cindy S ^b   Kiernan, Matthew C ^g  

^a Hallym University   (South Korea)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c Dept Medicine Endocrinol Diabet   (Singapore)

^d CHIBA UNIVERSITY   (Japan)

^e Dong A University   (South Korea)

^f University of Sydney   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY;

ACUTE MOTOR AXONAL NEUROPATHY; ASIA; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTRODIAGNOSIS; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOGENESIS; MOLECULAR MIMICRY; NERVE CONDUCTION DISORDER; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SERODIAGNOSIS;

EID: 84904121095     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306212     Document Type: Review

References (65)

1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294-304.
2. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bulletins et mémoires de la Société des Médecins des Hôpitaux de Paris 1916;40:1462-70.
3. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-26. (Pubitemid 17212981)
4. Yuki N, Yoshino H, Sato S, et al. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-2.
5. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-42. (Pubitemid 23103964)
6. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-44. (Pubitemid 26357889)
7. Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-35. (Pubitemid 26143601)
8. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 1969;48:173-215.
9. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 1996;25:33-51.
10. Kusunoki S. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies. Am J Med Sci 2000;319:234-9. (Pubitemid 30396583)
11. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A 2004;101:11404-9. (Pubitemid 39038359)
12. Takahashi M, Koga M, Yokoyama K, et al. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan. J Clin Microbiol 2005;43:335-9. (Pubitemid 40096320)
13. Uncini A, Manzoli C, Notturno F, et al. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010;81:1157-63.
14. Yuki N, Yamada M, Koga M, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001;49:712-20. (Pubitemid 32530237)
15. Susuki K, Nishimoto Y, Yamada M, et al. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 2003;54:383-8. (Pubitemid 37072042)
16. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-31.
17. Ogawara K, Kuwabara S, Koga M, et al. Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 2003;210:41-5. (Pubitemid 36539402)
18. Kuwabara S, Yuki N, Koga M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44:202-8. (Pubitemid 28374108)
19. Yuki N, Susuki K, Hirata K. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 2000;54:1851-3. (Pubitemid 30428417)
20. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-39.
21. Cornblath DR. Electrophysiology in Guillain-Barré syndrome. Ann Neurol 1990;27(Suppl):S17-20.
22. Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-8. (Pubitemid 28516049)
23. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
24. Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in the Guillain-Barré syndrome: distinguishing subtypes by published criteria. Muscle Nerve 1998;21:1275-9. (Pubitemid 28406709)
25. Kalita J, Misra UK, Das M. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2008;79:289-93. (Pubitemid 351303384)
26. van Asseldonk JT, van den Berg LH, Kalmijn S, et al. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37°C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain 2005;128:880-91. (Pubitemid 40516924)
27. Susuki K, Rasband MN, Tohyama K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-67. (Pubitemid 46597169)
28. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: an update. J Clin Neurosci 2009;16:733-41.
29. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain- Barré syndrome: a critical revision and the need for an update. Clin Neurophysiol 2012;123:1487-95.
30. McGrogan A, Madle GC, Seaman HE, et al. The epidemiology of Guillain-Barré syndrome worldwide: a systematic literature review. Neuroepidemiology 2009;32:150-63.
31. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
32. Omejec G, Podnar S. Retrospective analysis of Slovenian patients with Guillain-Barré syndrome. J Peripher Nerv Syst 2012;17:217-19.
33. Kushnir M, Klein C, Pollak L, et al. Evolving pattern of Guillain-Barré syndrome in a community hospital in Israel. Acta Neurol Scand 2008;117:347-50. (Pubitemid 351506434)
34. Shafqat S, Khealani BA, Awan F, et al. Guillain-Barré syndrome in Pakistan: similarity of demyelinating and axonal variants. Eur J Neurol 2006;13:662-5. (Pubitemid 43873641)
35. Nachamkin I, Arzarte Barbosa P, Ung H, et al. Patterns of Guillain-Barré syndrome in children: results from a Mexican population. Neurology 2007;69:1665-71. (Pubitemid 350287122)
36. Islam Z, Jacobs BC, van Belkum A, et al. Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology 2010;74:581-7.
37. Sayin R, Tombul T, Gulec TC, et al. Acute motor axonal neuropathy cases in Van region. Bratisl Lek Listy 2011;112:269-72.
38. Ye Y, Zhu D, Wang K, et al. Clinical and electrophysiological features of the 2007 Guillain-Barré syndrome epidemic in northeast China. Muscle Nerve 2010;42:311-14.
39. Kim JK, Bae JS, Kim DS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barré syndrome in Korea: nationwide multicenter study. J Clin Neurol (Accepted).
40. Paradiso G, Tripoli J, Galicchio S, et al. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal. Ann Neurol 1999;46:701-7. (Pubitemid 29518130)
41. Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr 2010;28:545-52.
42. Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandel GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th edn. Philadelphia: Churchill Livingstone Elsevier, 2010:2793-802.
43. Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter jejuni infections. Epidemiol Rev 1983;5:157-76. (Pubitemid 14238317)
44. Louis VR, Gillespie IA, O'Brien SJ, et al. Temperature-driven Campylobacter seasonality in England and Wales. Appl Environ Microbiol 2005;71:85-92. (Pubitemid 40116254)
45. Glass RI, Stoll BJ, Huq MI, et al. Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh. J Infect Dis 1983;148:292-6. (Pubitemid 13002464)
46. Calva JJ, Ruiz-Palacios GM, Lopez-Vidal AB, et al. Cohort study of intestinal infection with campylobacter in Mexican children. Lancet 1988;1:503-6. (Pubitemid 18059685)
47. Geleijns K, Brouwer BA, Jacobs BC, et al. The occurrence of Guillain-Barré syndrome within families. Neurology 2004;63:1747-50. (Pubitemid 39507609)
48. Saunders M, Rake M. Familial Guillain-Barré syndrome. Lancet 1965;2:1106-7.
49. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997;176(Suppl 2):S92-8. (Pubitemid 27505868)
50. Caporale CM, Papola F, Fioroni MA, et al. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes. J Neuroimmunol 2006;177:112-18. (Pubitemid 44108242)
51. Bremell T, Bjelle A, Svedhem A. Rheumatic symptoms following an outbreak of campylobacter enteritis: a five year follow up. Ann Rheum Dis 1991;50:934-8.
52. Koga M, Takahashi M, Masuda M, et al. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 2005;65:1376-81. (Pubitemid 41552764)
53. Kuwabara S. Does Campylobacter jejuni infection elicit axonal or demyelinating Guillain-Barré syndrome, or both? J Neurol Neurosurg Psychiatry 2011;82:238.
54. Ang CW, Koga M, Jacobs BC, et al. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands. J Neuroimmunol 2001;121:83-7. (Pubitemid 34008455)
55. Sekiguchi Y, Uncini A, Yuki N, et al. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study. J Neurol Neurosurg Psychiatry 2012;83:23-8.
56. Koga M, Ang CW, Yuki N, et al. Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The Netherlands. J Neurol Neurosurg Psychiatry 2001;70:693-5. (Pubitemid 32398012)
57. Drenthen J, Yuki N, Meulstee J, et al. Guillain-Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry 2011;82:300-5.
58. Kuwabara S, Ogawara K, Misawa S, et al. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome? Neurology 2004;63:529-33. (Pubitemid 39031386)
59. Mori M, Kuwabara S, Miyake M, et al. Haemophilus influenzae infection and Guillain-Barré syndrome. Brain 2000;123:2171-8.
60. Susuki K, Odaka M, Mori M, et al. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 2004;62:949-56. (Pubitemid 38435784)
61. Yuki N, Kuwabara S, Koga M, et al. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J Neurol Sci 1999;168:121-6. (Pubitemid 29467429)
62. Kuwabara S. Guillain-Barré syndrome. Curr Neurol Neurosci Rep 2007;7:57-62.
63. Capasso M, Notturno F, Manzoli C, et al. Involvement of sensory fibres in axonal subtypes of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2011;82:664-70.
64. Capasso M, Caporale CM, Pomilio F, et al. Acute motor conduction block neuropathy another Guillain-Barré syndrome variant. Neurology 2003;61:617-22. (Pubitemid 37082597)
65. Kaida K, Morita D, Kanzaki M, et al. Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 2007;182:212-18. (Pubitemid 46026709)